A Double Blind Placebo Controlled Study to Assess the Efficacy on Joint Damage in RA Patients

NCT00319917 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: tacrolimus
DRUG: placebo

Sponsor

Astellas Pharma Inc